dexmedetomidine has been researched along with Intracranial Hypertension in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Anstey, J; Bellomo, R; Jeffcote, T; Mcnamara, R; Udy, A; Weir, T | 1 |
| Hong, JH; Hwang, JH; Jeong, W; Kim, DH; Kim, E; Kim, YK; Koh, GH; Park, JY; Yu, J | 1 |
| Adams, JY; Duby, JJ; Louie, EL; Schomer, KJ; Sebat, CM; Shahlaie, K | 1 |
| Horiguchi, T; Kumagai, M; Masaki, Y; Nishikawa, T; Tobe, Y | 1 |
| Badjatia, N; Carpenter, AM; Choi, HA; Claassen, J; Fernandez, L; Gilmore, E; Ko, SB; Lee, K; Lesch, C; Malhotra, R; Mayer, SA; Presciutti, M; Schmidt, JM | 1 |
| Hall, SR; Hong, M; Milne, B; Wang, L | 1 |
1 review(s) available for dexmedetomidine and Intracranial Hypertension
| Article | Year |
|---|---|
The Impact of Sedative Choice on Intracranial and Systemic Physiology in Moderate to Severe Traumatic Brain Injury: A Scoping Review.
Topics: Adult; Analgesics, Opioid; Brain Injuries; Brain Injuries, Traumatic; Dexmedetomidine; Humans; Hypnotics and Sedatives; Intracranial Hypertension; Ketamine; Propofol; Prospective Studies | 2023 |
1 trial(s) available for dexmedetomidine and Intracranial Hypertension
| Article | Year |
|---|---|
Dexmedetomidine attenuates the increase of ultrasonographic optic nerve sheath diameter as a surrogate for intracranial pressure in patients undergoing robot-assisted laparoscopic prostatectomy: A randomized double-blind controlled trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Dexmedetomidine; Double-Blind Method; Head-Down Tilt; Humans; Intracranial Hypertension; Intracranial Pressure; Intraoperative Period; Laparoscopy; Male; Optic Nerve; Prostatectomy; Robotic Surgical Procedures; Treatment Outcome | 2019 |
4 other study(ies) available for dexmedetomidine and Intracranial Hypertension
| Article | Year |
|---|---|
Dexmedetomidine for Refractory Intracranial Hypertension.
Topics: Adult; Antihypertensive Agents; Brain Injuries; Dexmedetomidine; Female; Humans; Intracranial Hypertension; Male; Middle Aged; Retrospective Studies; Saline Solution, Hypertonic; Salvage Therapy; Treatment Outcome; Young Adult | 2019 |
Intravenous dexmedetomidine decreases lung permeability induced by intracranial hypertension in rats.
Topics: Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Animals; Capillary Permeability; Dexmedetomidine; Hemodynamics; Infusions, Intravenous; Intracranial Hypertension; Lung; Male; Microcirculation; Pulmonary Edema; Rats; Rats, Sprague-Dawley | 2008 |
Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Anticonvulsants; Conscious Sedation; Critical Care; Dexmedetomidine; Dose-Response Relationship, Drug; Female; Fever; Glasgow Coma Scale; Heart Arrest; Humans; Hypothermia, Induced; Intensive Care Units; Intracranial Hypertension; Magnesium Sulfate; Male; Meperidine; Middle Aged; Monitoring, Physiologic; Narcotics; Neuromuscular Nondepolarizing Agents; Propofol; Prospective Studies; Shivering; Vecuronium Bromide | 2011 |
Central dexmedetomidine attenuates cardiac dysfunction in a rodent model of intracranial hypertension.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Catecholamines; Dexmedetomidine; Disease Models, Animal; Electrocardiography; Heart Diseases; Heart Function Tests; Heart Rate; Hemodynamics; Intracranial Hypertension; Male; Malondialdehyde; Norepinephrine; Rats; Rats, Sprague-Dawley; Time Factors; Ventricular Function, Left | 2004 |